Despite weakened growth prospects, the stock trades at a market-typical P/E. Investors might face future letdowns if the P/E drops in line with the growth outlook. The stock price risks falling given the lukewarm earnings outlook paired with slower than market growth.
金域醫學股票討論區
暫無評論